Antibiotics
Sandoz Announces Plans for Joint Investment to Help Strengthen Future of Antibiotics Manufacturing in Europe
Sandoz
PR-M07-20-NI-38Jul 27, 2020
M&A
Sandoz Announces Agreement to Acquire Aspen’s Japanese Operations
Sandoz
PR-M11-19-NI-009Nov 13, 2019
FDA Approval
Sandoz Receives FDA Approval for Oncology Supportive Care Biosimilar Ziextenzo™
Sandoz
PR-M11-19-NI-006Nov 08, 2019
Recall
FDA Announces Voluntary Recall of Sandoz Ranitidine Capsules Following Detection of an Impurity
U.S. Food & Drug Administration
PR-M09-19-NI-049Sep 24, 2019
Recall
Sandoz Issues Voluntary Recall of Losartan
Nice Insight
PAO-M11-18-NI-016Nov 20, 2018
FDA Approval
Sandoz Inc. Announces US FDA Approval of Pediatric Dose of SYMJEPI™ (Epinephrine)
Sandoz
PR-M10-18-NI-007Oct 02, 2018
Annoucement
Novartis Unloads Sandoz US Components
Nice Insight
PAO-M09-18-NI-011Sep 14, 2018
Licensing Agreement
DURECT Announces Amendment to Licensing Agreement with Sandoz Related to POSIMIR® (SABER®-Bupivacaine)
DURECT Corporation
PR-M05-18-NI-042May 10, 2018
Acquisition
CASI Pharmaceuticals Acquires ANDA Portfolio From Sandoz Inc. (Sandoz)
CASI Pharmaceuticals, Inc.
PR-M02-18-NI-001Feb 01, 2018
Biosimilars
Sandoz - Biocon Deal One More Sign That U.S. Biosimilars Have Arrived
Kalorama Information
PR-M01-18-NI-086Jan 26, 2018
Regulatory
Sandoz regulatory submission for proposed biosimilar adalimumab accepted by FDA
Sandoz
PR-M01-18-NI-060Jan 19, 2018